|

ADT+second-generation antiandrogens ± chemotherapy Clinical Trials

1 actively recruiting trial

Also known as: hormonal therapy or chemotherapy

Pipeline

Phase 3: 1

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Therapy, Directly Observed1
  • Metastatic Prostate Cancer1
  • Cancer1

Other1 trial

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.